Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Michael Wortley (London, United Kingdom), Michael Wortley, John Adcock, Eric Dubuis, Sarah Maher, Sara Bonvini, Mark Birrell, Maria Belvisi. Anti-tussive effects of FAAH inhibition: The role of endocannabinoids and downstream signalling pathways in the inhibition of vagal sensory nerve activation. Eur Respir J 2015; 46: Suppl. 59, 3947

Member's Comments

No comment yet.

Related content which might interest you: BDNF-TrkB signaling mediates cholinergic neuroplasticity in asthma Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019 TRPV4 and activation of airway sensory nerves: The role of ATP Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 Decreased Wnt/β-catenin signaling in COPD: Possible involvement of Wnt antagonists Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases Year: 2012 Toll-like receptor stimulation induces airway hyperresponsiveness to bradykinin, an effect mediated by JNK and NF-κB signaling pathways Source: Eur Respir J 2005; 26: Suppl. 49, 732s Year: 2005 EPAC drives the anti-tussive effect of EP4 receptors on airway sensory nerves Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020 Different alcohols activate airway sensory nerves by a vanilloid receptor 1 (TRPV1) dependent mechanism Source: Eur Respir J 2003; 22: Suppl. 45, 415s Year: 2003 Eosinophil-induced intracellular signalling in cholinergic nerve cells Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003 Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Characterisation of TRPA1 activation on sensory nerves Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 VIP is an endogenous inhibitor of calcineurin-NFAT signalling Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension Year: 2009 Inhibition of sensory nerve activation by cannabinoid receptor activation in a model of gastroesophageal reflux in guinea pig Source: Eur Respir J 2005; 26: Suppl. 49, 101s Year: 2005 Activation of transient receptor potential (TRP) channels by hypoosmolar solution: an endogenous mechanism of ATP release and afferent nerve activation Source: International Congress 2017 – Novel studies on bronchodilators and cough Year: 2017 Glucocorticoids promote TGF-β signalling in lung fibroblasts by upregulating ligand and receptor expression, and uncoupling negative-feedback inhibition Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 TRPA1 activation in a human sensory neuronal model: relevance to cough hypersensitivity? Source: Eur Respir J, 50 (3) 1700995; 10.1183/13993003.00995-2017 Year: 2017 Inhibition of signal transduction pathways involved in inflammation Source: Eur Respir J 2003; 22: 16S-19S Year: 2003 Inhibition of signal transduction pathways involved in inflammation Source: Lung Science Conference 2003 - Inflammation and Respiratory Disease Year: 2003 The role of trigeminal afferents in up-regulation of cough Source: Annual Congress 2009 - From cough to sound analysis of breathing Year: 2009 NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD Source: Eur Respir J 2016; 47: 254-263 Year: 2016 Central role for the TRPV4-ATP-P2X3 axis in sensory nerve activation and the late asthmatic response Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016